XRTX
XORTX Therapeutics Inc.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 9/18/2026 | View on SEC |
| 6-K | 9/10/2026 | View on SEC |
| 6-K | 9/9/2026 | View on SEC |
| 6-K | 9/4/2026 | View on SEC |
| 6-K | 8/28/2026 | View on SEC |
| 6-K | 8/17/2026 | View on SEC |
| 6-K | 8/4/2026 | View on SEC |
| 6-K | 7/29/2026 | View on SEC |
| 6-K | 6/15/2026 | View on SEC |
| 6-K | 6/12/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | XRTX |
| Company Name | XORTX Therapeutics Inc. |
| CIK | 1729214 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | A1 |
| Phone | 403-607-2621 |